Early stage IT and Healthcare Investing

Aspreva

portfoliocompanies

company snapshot

Aspreva

Aspreva identified, developed and commercialized new indications for approved drugs and late-stage drug candidates for patients living with uncommon diseases. Aspreva had an initial public offering in 2006, then was acquired by Galenica Group in 2008 and was integrated into its Vifor Pharma business unit.

website
www.galenica.com
Leadership
Follow The Company
Investment Team
Facebook Google+ Twitter Email LinkedIn Share